Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-01-16

FDA Approved: OZEMPIC — Supplemental Application (Novo Nordisk)

View source ↗

Summary

The FDA approved a supplemental application for Ozempic to include an oral semaglutide formulation, expanding the product's delivery options for adults with typ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OZEMPIC (semaglutide)

Snippet

SUPPL AP for OZEMPIC (ORAL SEMAGLUTIDE)